Lumexa Imaging (LMRI) vs PROCEPT BioRobotics (PRCT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
PROCEPT BioRobotics is the larger company by market cap ($1.02 billion vs $990.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMRI | PRCT |
|---|---|---|
| Share price | $10.31 | $17.84 |
| Market cap | $990.53M | $1.02B |
| 1-day change | -2.64% | -0.39% |
| YTD return | -42.76% | -43.07% |
| 1-year return | — | -48.25% |
| 5-year return | — | -58.89% |
| Forward P/E | 11.58 | — |
| EPS (TTM) | $-0.37 | $-1.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.45 | $38.11 |
| 52-week low | $6.45 | $16.67 |
| Distance from 52-week high | -46.99% | -53.19% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +71.39% | +25.67% |
| Average volume | 428.00K | 1.44M |
| Shares outstanding | 96.07M | 56.92M |
| Employees | 5,000 | 888 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
About PROCEPT BioRobotics
PRCT stock →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia.
Health Care · Medical/Dental Instruments · 888 employees
LMRI vs PRCT FAQ
Which is bigger, Lumexa Imaging or PROCEPT BioRobotics?
PROCEPT BioRobotics (PRCT) is larger, with a market capitalization of $1.02B compared with $990.53M for Lumexa Imaging (LMRI).
Are Lumexa Imaging and PROCEPT BioRobotics in the same industry?
Both are in the Health Care sector, but in different industries: Medical Specialities for Lumexa Imaging and Medical/Dental Instruments for PROCEPT BioRobotics.